Osteoporosis: A Therapeutic Update

Patricia A. Mackey, Michael D. Whitaker

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Osteoporosis is now more apparent with the aging of the population and has become a serious health problem. The end-point of osteoporosis is fracture, which has economic, social, and psychological consequences for society. Some guidelines provide recommendations for whom to screen and treat. Various risk factors are associated with osteoporosis, with many being modifiable to prevent fractures. Both nonpharmacologic and pharmacologic therapies are available to reduce fracture risk. Pharmacologic intervention is predicated on an understanding of bone turnover with predictable outcomes noted. This review provides an update on prevention, screening, and treatment modalities for osteoporosis.

Original languageEnglish (US)
Pages (from-to)1011-1017
Number of pages7
JournalJournal for Nurse Practitioners
Volume11
Issue number10
DOIs
StatePublished - Nov 1 2015

Fingerprint

Osteoporosis
Bone Remodeling
Therapeutics
Economics
Guidelines
Psychology
Health
Population

Keywords

  • Anabolic
  • Antiresorptive
  • Bone density
  • Bone remodeling
  • Fracture

ASJC Scopus subject areas

  • LPN and LVN
  • Fundamentals and skills

Cite this

Osteoporosis : A Therapeutic Update. / Mackey, Patricia A.; Whitaker, Michael D.

In: Journal for Nurse Practitioners, Vol. 11, No. 10, 01.11.2015, p. 1011-1017.

Research output: Contribution to journalArticle

Mackey, Patricia A. ; Whitaker, Michael D. / Osteoporosis : A Therapeutic Update. In: Journal for Nurse Practitioners. 2015 ; Vol. 11, No. 10. pp. 1011-1017.
@article{079947f045e146d18d54f9b66fbef0ac,
title = "Osteoporosis: A Therapeutic Update",
abstract = "Osteoporosis is now more apparent with the aging of the population and has become a serious health problem. The end-point of osteoporosis is fracture, which has economic, social, and psychological consequences for society. Some guidelines provide recommendations for whom to screen and treat. Various risk factors are associated with osteoporosis, with many being modifiable to prevent fractures. Both nonpharmacologic and pharmacologic therapies are available to reduce fracture risk. Pharmacologic intervention is predicated on an understanding of bone turnover with predictable outcomes noted. This review provides an update on prevention, screening, and treatment modalities for osteoporosis.",
keywords = "Anabolic, Antiresorptive, Bone density, Bone remodeling, Fracture",
author = "Mackey, {Patricia A.} and Whitaker, {Michael D.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.nurpra.2015.08.010",
language = "English (US)",
volume = "11",
pages = "1011--1017",
journal = "Journal for Nurse Practitioners",
issn = "1555-4155",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Osteoporosis

T2 - A Therapeutic Update

AU - Mackey, Patricia A.

AU - Whitaker, Michael D.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Osteoporosis is now more apparent with the aging of the population and has become a serious health problem. The end-point of osteoporosis is fracture, which has economic, social, and psychological consequences for society. Some guidelines provide recommendations for whom to screen and treat. Various risk factors are associated with osteoporosis, with many being modifiable to prevent fractures. Both nonpharmacologic and pharmacologic therapies are available to reduce fracture risk. Pharmacologic intervention is predicated on an understanding of bone turnover with predictable outcomes noted. This review provides an update on prevention, screening, and treatment modalities for osteoporosis.

AB - Osteoporosis is now more apparent with the aging of the population and has become a serious health problem. The end-point of osteoporosis is fracture, which has economic, social, and psychological consequences for society. Some guidelines provide recommendations for whom to screen and treat. Various risk factors are associated with osteoporosis, with many being modifiable to prevent fractures. Both nonpharmacologic and pharmacologic therapies are available to reduce fracture risk. Pharmacologic intervention is predicated on an understanding of bone turnover with predictable outcomes noted. This review provides an update on prevention, screening, and treatment modalities for osteoporosis.

KW - Anabolic

KW - Antiresorptive

KW - Bone density

KW - Bone remodeling

KW - Fracture

UR - http://www.scopus.com/inward/record.url?scp=84945582587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945582587&partnerID=8YFLogxK

U2 - 10.1016/j.nurpra.2015.08.010

DO - 10.1016/j.nurpra.2015.08.010

M3 - Article

AN - SCOPUS:84945582587

VL - 11

SP - 1011

EP - 1017

JO - Journal for Nurse Practitioners

JF - Journal for Nurse Practitioners

SN - 1555-4155

IS - 10

ER -